Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Acta Radiologica (Stockholm, Sweden : 1987)|June 15, 2018
CT colonography: implementation, indications, and technical performance - a follow-up national surveyFredrik Thorén, Åse A Johnsson, John Brandberg, et al.Radiation Protection Dosimetry|April 15, 2021
EXTRACOLONIC FINDINGS-IDENTIFICATION AT LOW-DOSE CTCFredrik Thorén, Åse A Johnsson, Mikael Hellström, et al.Journal of Leukocyte Biology|September 14, 2004
Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytesMarkus Hansson, Ana Romero, Fredrik Thorén, et al.Journal of Leukocyte Biology|September 17, 2004
A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicalsFredrik Thorén, Ana Romero, Magnus Lindh, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functionsLars Bellner, Fredrik Thorén, Erik Nygren, et al.Plos One|November 5, 2016
The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of ComplicationsAnna Rydén, Elisabeth Sörstadius, Klas Bergenheim, et al.Diabetes Care|October 25, 2018
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week StudyParesh Dandona, Chantal Mathieu, Moshe Phillip, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104)Anne Marie Asemissen, Carmen Scheibenbogen, Anne Letsch, et al.Diabetes Care|April 11, 2019
Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2Chantal Mathieu, Paresh Dandona, Moshe Phillip, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 11, 2020
Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial ProgrammeJason Gordon, Thomas Danne, Lee Beresford-Hulme, et al.Pageof 2